Signaling Pathways
-
B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl inhibitor
-
B1498 I-BET-7624 CitationTarget: BromodomainsSummary: BET inhibitor,highly potent
-
B2284 Fostamatinib (R788)Target: SykSummary: Spleen tyrosine kinase (Syk) inhibitor
-
B1439 Golvatinib (E7050)Target: VEGFRSummary: C-Met/VEGFR-2 inhibitor
-
B1598 Biperiden HCl1 CitationTarget: M1 ReceptorsSummary: Anticholinergic drug
-
B2075 AmbrisentanTarget: ETA ReceptorsSummary: ETA-receptor antagonist
-
B2136 ZanamivirTarget: Influenza virusesSummary: Influenza A/B virus neuraminidases inhibitor
-
B2189 YM201636Target: PIKfyveSummary: PIKfyve inhibitor,potent and selective
-
B1500 I-BET151 (GSK1210151A)2 CitationTarget: Bromodomain and Extra-Terminal motif (BET)Summary: Selective BET inhibitor
-
B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator